课题基金 / 基金详情

I-Corps: From Compacts to Integrated Systems: A New Paradigm for the Design and Manufacture of Pharmaceuticals

I-Corps: From Compacts to Integrated Systems: A New Paradigm for the Design and Manufacture of Pharmaceuticals
I-Corps:从紧凑型到集成系统:药品设计和制造的新范式
批准号:
1405462
负责人:
Rodolfo Pinal
金额:
$5.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-02-01 至 2015-07-31

项目摘要

项目成果

Rodolfo Pinal的其他基金

相似基金

相关文献

中文摘要
翻译
提议的团队为药物剂型的设计和制造引入了一种新的范例。新平台技术3D集成制药(3D IP)的灵感来自3D IC (3D集成电路)模型所实现的令人印象深刻的进展。所提出的方法的基本概念对制药业来说是新颖的,包括将药品视为综合系统。使用3D IP,剂型由预制的工作组件组装而成,根据预先建立的蓝图,而不是通过混合和压缩粉末。结果是一种相对简单的方法来制造具有定制形状,物理尺寸,最重要的是药物释放曲线的药品。3D IP是一个新颖的平台,专注于生产药物口服剂型。类似于3D集成电路的设计,通过多个功能组件的3D层堆叠构建,3D IP剂型通过堆叠预制的活性成分载体、增溶功能、ID/防伪、防篡改等功能组件组装而成。3D IP技术可应用于需要针对目标或活性化合物进行定制释放的领域,其应用范围从口服药物扩展到透皮市场、智能贴片、农用化学品、营养药品和个人护理产品。
英文摘要
The proposed team introduces a new paradigm for the design and manufacture of pharmaceutical dosage forms. The new platform technology, 3D Integrated Pharmaceuticals (3D IP), is inspired after the impressive progress realized by the 3D IC (3D Integrated Circuits) model. The underlying concept of the proposed approach, novel to the pharmaceutical industry, consists in looking at pharmaceutical products as integrated systems. With 3D IP, dosage forms are assembled from pre-fabricated working components, according to a pre-established blueprint instead of by blending and compressing powders. The result is a comparatively simple means of making pharmaceutical products with customized shape, physical dimensions, and most importantly, drug release profile. 3D IP is a novel platform that has focused on producing pharmaceutical oral dosage forms. Analogous to the design of 3D integrated circuits, built by the 3D layer stacking of multiple functional components, 3D IP dosage forms are assembled by stacking pre-fabricated functional components such as active ingredient carrier, solubilizing function, ID/anti-counterfeiting, and tamper prevention. The 3D IP technology has applications in areas where customizable release for a target or active compound is needed, which extend beyond oral pharmaceuticals, into transdermal markets, smart patches, agrochemicals, nutraceuticals and personal care products.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSF I/UCRC in Pharmaceutical Processing
  • 批准号:
    0003064
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $29.0万
  • 财政年份:
    2000
  • 负责人:
    Rodolfo Pinal
  • 依托单位:
海外基金